Vimarsana
Biggest News Aggregation in the World

Page 2 - Active Comparator News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active Comparator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Comparator Today - Breaking & Trending Today

U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis - Vimarsana News

U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis

Published: January 21, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of...

Source: prnewswire.com
Related Topics:
Midi PyréesAnn Dermatol VenereolClin RheumatolThomas HudsonAlanj KivitzBoehringer IngelheimDrug AdministrationHealth Assessment QuestionnaireAmerican College Of RheumatologyExchange CommissionAltoona CenterClinical ResearchAbbvie IncOsteoporosis CenterAltoona ArthritisPivotal PhasePsoriasis Area Severity IndexHealth Assessment Questionnaire Disability IndexAllergic ReactionsAbbvie AssistImportant SafetyFull Prescribing InformationMedication GuideAllergan AestheticsPrivate Securities Litigation Reform Act
U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis - Vimarsana News

U.S. FDA Approves Second Indication for SKYRIZI® (risankizumab-rzaa) to Treat Adults with Active Psoriatic Arthritis

Published: January 21, 2022

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of...

Source: prnewswire.com
Related Topics:
Midi PyréesAnn Dermatol VenereolClin RheumatolThomas HudsonAlanj KivitzBoehringer IngelheimDrug AdministrationHealth Assessment QuestionnaireAmerican College Of RheumatologyExchange CommissionAltoona CenterClinical ResearchAbbvie IncOsteoporosis CenterAltoona ArthritisPivotal PhasePsoriasis Area Severity IndexHealth Assessment Questionnaire Disability IndexAllergic ReactionsAbbvie AssistImportant SafetyFull Prescribing InformationMedication GuideAllergan AestheticsPrivate Securities Litigation Reform Act